Schertenleib
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Patent litigation and regulatory disputes work is at the heart of Schertenleib’s healthcare and life sciences practice, with the team acting for clients across the pharmaceutical, medical devices and cosmetics industries. Spearheading the team, Denis Schertenleib excels in multinational litigation, in particular IP matters. Ombeline Degèze-Péchade’s extensive expertise encompasses complex regulatory frameworks and covert market strategies, while Marc Lauzeral is a name to note for cross-border patent and SPC disputes.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘A competent, attentive, and adaptable team provides genuine support to the client, taking into account their specific needs and constraints.’
- ‘Ombeline Degèze-Péchade is extremely responsive and provides brilliant advice due to her extensive knowledge and experience. Ombeline and the Schertenleib law firm are definitely a go-to address for all healthcare and life sciences related questions.’
Key clients
- Recor Medical Inc. & Otsuka Medical Device Viatris Neuraxpharm Sandoz Zentiva Filorga Fill-Med Bio-Rad
Work highlights
Represented Sandoz in invalidity proceedings against Bayer’s patent relating to Rivaroxaban, one of Bayer’s blockbuster drugs and a strategic product for the client’s European portfolio.